What does Dr. Matthias Dupont do?

Dr. Matthias Dupont is a specialist medical practice in Hasselt. Private Limited, started on 12 November 2012, 1 establishment.

What is the address of Dr. Matthias Dupont?

The registered office of Dr. Matthias Dupont is located at Vossenbergstraat 85, 3500 Hasselt.

Is Dr. Matthias Dupont still active?

Yes. According to the CBE (30 October 2026) Dr. Matthias Dupont is active, legal situation “Normale toestand”, started on 12 November 2012.

Is Dr. Matthias Dupont registered on Peppol?

Yes, Dr. Matthias Dupont is registered on the Peppol network with ID 0208:0500744979.

What is the enterprise number of Dr. Matthias Dupont?

The enterprise number of Dr. Matthias Dupont is BE0500744979.

When was Dr. Matthias Dupont founded?

Dr. Matthias Dupont was founded on 12 November 2012.

Who are the directors of Dr. Matthias Dupont?

According to the 2025 annual accounts, the directors of Dr. Matthias Dupont are: Matthias Dupont.

Is Dr. Matthias Dupont a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 12 November 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Matthias Dupont make in 2025?

Dr. Matthias Dupont posted a profit after taxes of € 459,833 in financial year 2025.

What is the revenue of Dr. Matthias Dupont?

As a small company, Dr. Matthias Dupont is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 702,092.

Dr. Matthias Dupont (Private Limited) - Hasselt

Dossier Dr. Matthias Dupont, printed on 30 October 2026 from databakkes.be/en/0500744979/dr-matthias-dupont. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Matthias Dupont from Hasselt, company number BE0500744979, closed financial year 2025 with a result of € 459,833 after tax. For that financial year Dr. Matthias Dupont recorded a gross margin of € 702,092 and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 373,957 to € 459,833. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 1, 2026.

What it is worth Growing

€ 3.1 million

▲ 13% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 459,833

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 538,052

▲ 39% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 105,263 paid out

23 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 57,318

▼ 32% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 498,327

▼ 21% vs 2024

€ 131,202 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 771

▼ 67% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 123,317

▲ 112% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 668,034 Gross margin 2022: € 668,034 First fiscal year in the series	€ 620,093 Gross margin 2023: € 620,093 ▼ 7% vs 2022 (€ 668,034) Unfavourable step	€ 703,014 Gross margin 2024: € 703,014 ▲ 13% vs 2023 (€ 620,093) Favourable step	€ 702,092 Gross margin 2025: € 702,092 Unchanged (€ 703,014) Unfavourable step
Profit after taxes	€ 386,544 Profit after taxes 2022: € 386,544 First fiscal year in the series	€ 361,072 Profit after taxes 2023: € 361,072 ▼ 7% vs 2022 (€ 386,544) Unfavourable step	€ 373,957 Profit after taxes 2024: € 373,957 ▲ 4% vs 2023 (€ 361,072) Favourable step	€ 459,833 Profit after taxes 2025: € 459,833 ▲ 23% vs 2024 (€ 373,957) Favourable step	▲ 23%
Equity	€ 2,301,237 Equity 2022: € 2,301,237 First fiscal year in the series	€ 2,512,098 Equity 2023: € 2,512,098 ▲ 9% vs 2022 (€ 2,301,237) Favourable step	€ 2,734,476 Equity 2024: € 2,734,476 ▲ 9% vs 2023 (€ 2,512,098) Favourable step	€ 3,089,046 Equity 2025: € 3,089,046 ▲ 13% vs 2024 (€ 2,734,476) Favourable step	▲ 13%
Total debts	€ 966,760 Total debts 2022: € 966,760 First fiscal year in the series	€ 861,500 Total debts 2023: € 861,500 ▼ 11% vs 2022 (€ 966,760) Favourable step	€ 832,746 Total debts 2024: € 832,746 ▼ 3% vs 2023 (€ 861,500) Favourable step	€ 726,516 Total debts 2025: € 726,516 ▼ 13% vs 2024 (€ 832,746) Favourable step	▼ 13%
Cash	€ 517,917 Cash 2022: € 517,917 First fiscal year in the series	€ 521,098 Cash 2023: € 521,098 ▲ 1% vs 2022 (€ 517,917) Favourable step	€ 386,780 Cash 2024: € 386,780 ▼ 26% vs 2023 (€ 521,098) Unfavourable step	€ 538,052 Cash 2025: € 538,052 ▲ 39% vs 2024 (€ 386,780) Favourable step	▲ 39%
Land & buildings	€ 1,795,736 Land & buildings 2022: € 1,795,736 First fiscal year in the series	€ 1,715,905 Land & buildings 2023: € 1,715,905 ▼ 4% vs 2022 (€ 1,795,736) Unchanged	€ 1,637,940 Land & buildings 2024: € 1,637,940 ▼ 5% vs 2023 (€ 1,715,905) Unchanged	€ 1,566,945 Land & buildings 2025: € 1,566,945 ▼ 4% vs 2024 (€ 1,637,940) Unchanged	▼ 4%
Retained profit	€ 2,288,837 Retained profit 2022: € 2,288,837 First fiscal year in the series	€ 2,499,698 Retained profit 2023: € 2,499,698 ▲ 9% vs 2022 (€ 2,288,837) Favourable step	€ 2,722,076 Retained profit 2024: € 2,722,076 ▲ 9% vs 2023 (€ 2,499,698) Favourable step	€ 3,076,646 Retained profit 2025: € 3,076,646 ▲ 13% vs 2024 (€ 2,722,076) Favourable step	▲ 13%
Dividend	€ 100,000 Dividend 2022: € 100,000 First fiscal year in the series	€ 150,211 Dividend 2023: € 150,211 ▲ 50% vs 2022 (€ 100,000) Unchanged	€ 151,579 Dividend 2024: € 151,579 ▲ 1% vs 2023 (€ 150,211) Unchanged	€ 105,263 Dividend 2025: € 105,263 ▼ 31% vs 2024 (€ 151,579) Unchanged	▼ 31%
Bank debt	€ 884,236 Bank debt 2022: € 884,236 First fiscal year in the series	€ 756,849 Bank debt 2023: € 756,849 ▼ 14% vs 2022 (€ 884,236) Favourable step	€ 628,223 Bank debt 2024: € 628,223 ▼ 17% vs 2023 (€ 756,849) Favourable step	€ 498,327 Bank debt 2025: € 498,327 ▼ 21% vs 2024 (€ 628,223) Favourable step	▼ 21%
Balance sheet total	€ 3,267,997 Balance sheet total 2022: € 3,267,997 First fiscal year in the series	€ 3,373,598 Balance sheet total 2023: € 3,373,598 ▲ 3% vs 2022 (€ 3,267,997) Unchanged	€ 3,567,222 Balance sheet total 2024: € 3,567,222 ▲ 6% vs 2023 (€ 3,373,598) Unchanged	€ 3,815,561 Balance sheet total 2025: € 3,815,561 ▲ 7% vs 2024 (€ 3,567,222) Unchanged	▲ 7%

Key figures of Dr. Matthias Dupont, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Matthias Dupont?

What happened at Dr. Matthias Dupont in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 1, 2026 New annual accounts for financial year 2025: profit of € 459,833 (▲ 23% vs 2024). Source: NBB ↗
Nov 12, 2012 New establishment in Hasselt. KBO
2012 Matthias Dupont became a director. NBB
Nov 12, 2012 Start of the company according to the CBE. KBO

In short

From € 386,544 profit in 2022 to € 459,833 profit in 2025.

Paid € 738,581 in corporate taxes since 2022.

Best year ever: 2025, with € 459,833 profit.

Paid out € 507,053 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

DR PETRA NIJST - CARDIOLOGIE 5%

The stake of DR PETRA NIJST - CARDIOLOGIE comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

Dr. Matthias Dupont

HLG 8.3%

Behind Dr. Matthias Dupont is Matthias Dupont. The shares are held by DR PETRA NIJST - CARDIOLOGIE (5%). It owns 8.3% of HLG itself.

Directors

According to the 2025 annual accounts

Matthias Dupont

Director

Also active at: HLG, Hartcentrum Hoeselt, CARDIOTRIALS ZOL

since 2012

Shareholders

DR PETRA NIJST - CARDIOLOGIE

Participations

HLG

8.3%

Establishments

Establishment units

Physical locations of this company

Registered office

Vossenbergstraat 85

3500 Hasselt

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0500.744.979

VAT number

BE 0500.744.979

Registered office

Vossenbergstraat 85, 3500 Hasselt

Names & denominations

Dr. Matthias Dupont

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

12 November 2012

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Activiteiten van medisch specialisten

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Matthias Dupont

Financials

What happened to Dr. Matthias Dupont?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions